Mustang Bio, Inc.
MBIO
$1.54
-$0.11-6.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -762.00K | -153.00K | -952.00K | -1.41M | -8.20M |
| Total Depreciation and Amortization | 0.00 | 41.00K | 75.00K | 51.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -751.00K | -140.00K | 2.09M | 71.00K | 1.20M |
| Change in Net Operating Assets | 174.00K | -1.14M | -3.21M | -469.00K | 4.66M |
| Cash from Operations | -1.34M | -1.39M | -2.00M | -1.76M | -2.34M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 1.17M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 1.17M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 7.62M | 5.56M | 1.16M | 5.27M |
| Repurchase of Common Stock | -235.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -626.00K | -149.00K | -- |
| Cash from Financing | -235.00K | 7.62M | 4.94M | 1.01M | 5.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.57M | 7.39M | 2.94M | -743.00K | 2.93M |